Sectors
RLMD
Relmada Therapeutics, Inc.
4.36
1 x 4.31
1 x 4.37
bid
ask
+
0.03
0.69%
1 @ 07:30 PM
4.36 +0.00 (0.00%)
| Ytd | -9.73% | |
| 1y | 289.29% |
4.29
day range
4.39
1.06
52 week range
8.00
| Open | 4.31 | Prev Close | 4.33 | Low | 4.29 | High | 4.39 | Mkt Cap | 465.08M |
| Vol | 628.24K | Avg Vol | 1.73M | EPS | -0.91 | P/E | N/A | Forward P/E | -0.19 |
| Beta | 0.41 | Short Ratio | 4.52 | Inst. Own | 46.06% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 5.53 | 200-d Avg | 5.46 | 1yr Est | 0.87 |
| Income Statement | |||
| Operating Expenses | 15.01M | ||
| Research and Development Expense | 8.39M | ||
| Selling, General and Administrative Expense | 6.62M | ||
| Operating Income | -15.01M | ||
| Net Income | -12.91M | ||
| Net Income Common Stock | -12.91M | ||
| Net Income Common Stock (USD) | -12.91M | ||
| Consolidated Income | -12.91M | ||
| Earnings per Basic Share | -0.11 | ||
| Earnings per Basic Share (USD) | -0.11 | ||
| Earnings per Diluted Share | -0.11 | ||
| Earning Before Interest & Taxes (EBIT) | -12.91M | ||
| Earning Before Interest & Taxes (USD) | -12.91M | ||
| Weighted Average Shares | 112.38M | ||
| Weighted Average Shares Diluted | 112.38M | ||
| Balance Sheet | |||
| Cash and Equivalents | 11.33M | ||
| Cash and Equivalents (USD) | 11.33M | ||
| Investments | 206.40M | ||
| Investments Current | 206.40M | ||
| Trade and Non-Trade Receivables | 10.91K | ||
| Current Assets | 219.04M | ||
| Total Assets | 219.06M | ||
| Current Liabilities | 7.42M | ||
| Total Liabilities | 12.50M | ||
| Accumulated Retained Earnings (Deficit) | -730.23M | ||
| Shareholders Equity | 206.56M | ||
| Shareholders Equity (USD) | 206.56M | ||
| Assets Non-Current | 19.50K | ||
| Liabilities Non-Current | 5.08M | ||
| Trade and Non-Trade Payables | 2.41M | ||
| Cash Flow | |||
| Net Cash Flow from Financing | -6.42M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 1.56M | ||
| Issuance (Purchase) of Equity Shares | -6.36M | ||
| Net Cash Flow from Investing | 17.59M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 17.59M | ||
| Net Cash Flow from Operations | -9.61M | ||
| Share Based Compensation | 2.24M | ||